Light emitting diode-generated blue light modulates fibrosis characteristics: Fibroblast proliferation, migration speed, and reactive oxygen species generation

Lasers in Surgery and Medicine

Volumn 47, Issue 2, 2015, Pages 210-215

  Mamalis, Andrew ^a,b   Garcha, Manveer ^a   Jagdeo, Jared ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c Downstate Health Sciences University   (United States)

Author keywords

Blue LED; Fibrosis; Light emitting diode; Reactive oxygen species

Indexed keywords

REACTIVE OXYGEN METABOLITE; TRYPAN BLUE;

ADULT; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; IRRADIATION; LIGHT EMITTING DIODE BLUE LIGHT PHOTOTHERAPY; PHOTOTHERAPY; PRIORITY JOURNAL; SKIN FIBROBLAST; SKIN FIBROSIS; TIME-LAPSE VIDEO MICROSCOPY; CELL MOTION; CULTURE TECHNIQUE; FIBROBLAST; FIBROSIS; LIGHT; METABOLISM; PATHOLOGY; PHYSIOLOGY; RADIATION RESPONSE; SKIN;

ADULT; CELL CULTURE TECHNIQUES; CELL MOVEMENT; CELL PROLIFERATION; FIBROBLASTS; FIBROSIS; HUMANS; LIGHT; REACTIVE OXYGEN SPECIES; SKIN;

EID: 84923797490     PISSN: 01968092     EISSN: 10969101     Source Type: Journal    
DOI: 10.1002/lsm.22293     Document Type: Article

References (32)

1. Uitto J. The role of elastin and collagen in cutaneous aging: Intrinsic aging versus photoexposure. J Drugs Dermatol 2008;7(2 Suppl):12-16.
2. Marrot L, Meunier JR. Skin DNA photodamage and its biological consequences. J Am Acad Dermatol 2008;58(5 Suppl 2):S139-S148.
3. Liebel F, Kaur S, Ruvolo E, Kollias N, Southall MD. Irradiation of skin with visible light induces reactive oxygen species and matrix-degrading enzymes. J Invest Dermatol 2012;132(7):1901-1907.
4. Morton CA, Scholefield RD, Whitehurst C, Birch J. An open study to determine the efficacy of blue light in the treatment of mild to moderate acne. J Dermatolo Treat 2005;16(4):219-223.
5. Russell BA, Kellett N, Reilly LR. A study to determine the efficacy of combination LED light therapy (633 nm and 830 nm) in facial skin rejuvenation. J Cosmet Laser Ther 2005;7(3-4):196-200.
6. Mamalis AD, Lev-Tov H, Nguyen DH, Jagdeo JR. Laser and light-based treatment of Keloids - A review. J Eur Acad Dermatol Venereol 2013.
7. Huang YY, Sharma SK, Carroll J, Hamblin MR. Biphasic dose response in low level light therapy - An update. Dose Response 2011;9(4):602-618.
8. Losi A. Flavin-based Blue-Light photosensors: A photobiophysics update. Photochem Photobiol 2007;83(6):1283-1300.
9. Taflinski L, Demir E, Kauczok J, Fuchs PC, Born M, Suschek CV, Oplander C. Blue light inhibits transforming growth factor-beta1-induced myofibroblast differentiation of human dermal fibroblasts. Exp Dermatol 2014;23(4):240-246.
10. Oplander C, Hidding S, Werners FB, Born M, Pallua N, Suschek CV. Effects of blue light irradiation on humandermal fibroblasts. Journal of photochemistry and photobiology B. Biology 2011;103(2):118-125.
11. Kolbe L. How much sun protection is needed?: Are we on the way to full-spectrum protection? J Invest Dermatol 2012;132(7):1756-1757.
12. Mahmoud BH, Ruvolo E, Hexsel CL, Liu Y, Owen MR, Kollias N, Lim HW, Hamzavi IH. Impact of long-wavelength UVA and visible light on melanocompetent skin. J Invest Dermatol 2010;130(8):2092-2097.
13. Samarakoon R, Overstreet JM, Higgins PJ. TGF-beta signaling in tissue fibrosis: Redox controls, target genes and therapeutic opportunities. Cell Signal 2013;25(1):264-268.
14. Bayat A, McGrouther DA, Ferguson MW. Skin scarring. BMJ 2003;326(7380):88-92.
15. Yang YC, Cheng YW, Lai CS, Chen W. Prevalence of childhood acne, ephelides, warts, atopic dermatitis, psoriasis, alopecia areata and keloid in Kaohsiung County, Taiwan: A community-based clinical survey. J Eur Acad Dermatol Venereol 2007;21(5):643-649.
16. Chen GY, Cheng YW, Wang CY, Hsu TJ, Hsu MM, Yang PT, Chen WC. Prevalence of skin diseases among schoolchildren in Magong, Penghu, Taiwan: A community-based clinical survey. J Formos Med Assoc 2008;107(1):21-29.
17. Abdullah A, Blakeney P, Hunt R, Broemeling L, Phillips L, Herndon DN, Robson MC. Visible scars and self-esteem in pediatric patients with burns. J Burn Care Rehabil 1994;15(2):164-168.
18. Bock O, Schmid-Ott G, Malewski P, Mrowietz U. Quality of life of patients with keloid and hypertrophic scarring. Arch Dermatol Res 2006;297(10):433-438.
19. Brych SB, Engrav LH, Rivara FP, Ptacek JT, Lezotte DC, Esselman PC, Kowalske KJ, Gibran NS. Time off work and return to work rates after burns: Systematic review of the literature and a large two-center series. J Burn Care Rehabil 2001;22(6):401-405.
20. Engrav LH, Heimbach DM, Reus JL, Harnar TJ, Marvin JA. Early excision and grafting vs. nonoperative treatment of burns of indeterminant depth: A randomized prospective study. J Trauma 1983;23(11):1001-1004.
21. Fauerbach JA, Heinberg LJ, Lawrence JW, Munster AM, Palombo DA, Richter D, Spence RJ, Stevens SS, Ware L, Muehlberger T. Effect of early body image dissatisfaction on subsequent psychological and physical adjustment after disfiguring injury. Psychosom Med 2000;62(4):576-582.
22. Fauerbach JA, Heinberg LJ, Lawrence JW, Bryant AG, Richter L, Spence RJ. Coping with body image changes following a disfiguring burn injury. Health psychology: official journal of the division of health psychology. American Psychological Association 2002;21(2):115-121.
23. Zhu KQ, Carrougher GJ, Gibran NS, Isik FF, Engrav LH. Review of the female Duroc/Yorkshire pig model of human fibroproliferative scarring. Wound Repair Regen 2007;15(Suppl 1):S32-39.
24. Mura G, Bhat KM, Pisano A, Licci G, Carta M. Psychiatric symptoms and quality of life in systemic sclerosis. Clin Pract Epidemiol Ment Health 2012;8:30-35.
25. Hummers LK, Wigley FM. Scleroderma. Current rheumatology diagnosis & treatment. 2nd edition. New York: McGraw-Hill 2007.
26. Lev-Tov H, Brody N, Siegel D, Jagdeo J. Inhibition of fibroblast proliferation in vitro using low-level infrared light-emitting diodes. Dermatol Surg 2013;39(3 Pt 1):422-425.
27. Lev-Tov H, Mamalis A, Brody N, Siegel D, Jagdeo J. Inhibition of fibroblast proliferation in vitro using red light-emitting diodes. Dermatol Surg 2013;39(8):1167-1170.
28. Chen J, Hoffman BB, Isseroff RR. Beta-adrenergic receptor activation inhibits keratinocyte migration via a cyclic adenosine monophosphate-independent mechanism. J Invest Dermatol 2002;119(6):1261-1268.
29. Jagdeo J, Adams L, Lev-Tov H, Sieminska J, Michl J, Brody N. Dose-dependent antioxidant function of resveratrol demonstrated via modulation of reactive oxygen species in normal human skin fibroblasts in vitro. J Drugs Dermatol 2010;9(12):1523-1526.
30. Malcic AI, Pavicic I, Trosic I, Simeon P, Katanec D, Krmek SJ. The effects of bluephase LED light on fibroblasts. Eur J Dent 2012;6(3):311-317.
31. Ashcroft KJ, Syed F, Bayat A. Site-specific keloid fibroblasts alter the behaviour of normal skin and normal scar fibroblasts through paracrine signalling. PloS one 2013;8(12):e75600.
32. Wu CS, Wu PH, Fang AH, Lan CC. FK506 inhibits the enhancing effects of transforming growth factor (TGF)-beta1 on collagen expression and TGF-beta/Smad signalling in keloid fibroblasts: Implication for new therapeutic approach. Br J Dermatol 2012;167(3):532-541.